687 related articles for article (PubMed ID: 29691646)
1. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of sentinel lymph node mapping for endometrial cancer.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
[TBL] [Abstract][Full Text] [Related]
6. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
9. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic near-infrared fluorescent imaging as an alternative option for sentinel lymph node mapping in endometrial cancer: A prospective study.
Taşkın S; Şükür YE; Altın D; Ersöz CC; Turgay B; Kankaya D; Güngör M; Ortaç F
Int J Surg; 2017 Nov; 47():13-17. PubMed ID: 28919095
[TBL] [Abstract][Full Text] [Related]
13. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
[TBL] [Abstract][Full Text] [Related]
15. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
18. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
19. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
[TBL] [Abstract][Full Text] [Related]
20. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
